GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » Short Interest

Functional Technologies (TSXV:FEB.H) Short Interest


View and export this data going back to . Start your Free Trial

What is Functional Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Functional Technologies's Short Interest

For the Biotechnology subindustry, Functional Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Functional Technologies's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Functional Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where Functional Technologies's Short Interest falls into.



Functional Technologies (TSXV:FEB.H) Business Description

Traded in Other Exchanges
N/A
Address
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies (TSXV:FEB.H) Headlines

No Headlines